Inactive Instrument

News Neurokine Pharmaceuticals Inc Other OTC

Equities

CAC611561100

End-of-day quote Other OTC Other stock markets
- ^USD	-

May. 01	BetterLife Pharma Advances IND-enabling Studies For BETR-001	MT
May. 01	BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BetterLife Announces Intent to Complete Private Placement of Units	May. 03	AQ
BetterLife Pharma Advances IND-enabling Studies For BETR-001	May. 01	MT
BetterLife Advances BETR-001 IND-enabling Studies	May. 01	GL
BetterLife Advances BETR-001 IND-enabling Studies	May. 01	AQ
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies	May. 01	CI
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 15	NE
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 11	GL
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 11	AQ
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	Apr. 03	GL
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	Apr. 03	AQ
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	Apr. 02	CI
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	Mar. 04	GL
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	Mar. 04	AQ
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	Mar. 03	CI
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding	Mar. 03	CI
BetterLife Closes Convertible Debentures For Further Development of BETR-001	Jan. 02	MT
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	Jan. 02	GL
BetterLife Pharma Inc. announced that it has received CAD 0.3 million in funding	Jan. 01	CI
BetterLife Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 29	CI
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	Dec. 29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Neurokine Pharmaceuticals Inc Other OTC

Equities

CAC611561100

Summary

Filters